Using decision forest to classify prostate cancer samples on the basis of SELDI-TOF MS data: assessing chance

Weida Tong1, Qian Xie, Huixiao Hong

  • 1Center for Toxicoinformatics, Division of Biometry and Risk Assessment, National Center for Toxicological Research/FDA, 3900 NCTR Road, HFT020, Jefferson, AK 72079, USA. wtong@nctr.fda.gov

Related Concept Videos